Renato Scalone

ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial

Massimo Federico, Stefano Luminari, Emilio Iannitto et al. · Journal of Clinical Oncology · 2009 · 270 citations · Full text

Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi et al. · Clinical Infectious Diseases · 2017 · 151 citations · Full text

Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans Syndrome

Maurizio Musso, Ferdinando Porretto, Alessandra Crescimanno et al. · Lupus · 1998 · 78 citations

Cell Therapy, Immunology, Allogeneic Stem Cell +19

Palonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy

Maurizio Musso, Renato Scalone, Vincenza Bonanno et al. · Supportive Care in Cancer · 2008 · 47 citations

Oncology, Medicine, Metronomic Therapy +7

Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study

Maurizio Musso, Renato Scalone, Gianpaolo Marcacci et al. · Bone Marrow Transplantation · 2009 · 43 citations · Full text

Lymphoid Neoplasia, Oncology, Multicenter Feasibility Study +5